Robert Foronjy
Papers
1
Total Citations
343
H-Index
1
About
Dr. Robert Foronjy is a leading pulmonary researcher whose work has fundamentally shaped our understanding of how inhaled toxins—from tobacco smoke to electronic cigarettes—drive chronic lung disease. His research centers on the molecular mechanisms of Chronic Obstructive Pulmonary Disease (COPD) and the pulmonary effects of emerging nicotine delivery systems. Foronjy’s landmark 2016 study, cited over 340 times, provided the first definitive evidence that chronic e-cigarette exposure in mice induces hallmark features of COPD in a nicotine-dependent manner, directly challenging the perception of e-cigarettes as harmless alternatives. This pivotal work has been instrumental in guiding public health policy and clinical perspectives on vaping. Beyond this, his broader contributions have elucidated key pathways in emphysema and airway remodeling, demonstrating how oxidative stress and protease activity drive lung destruction. With a career spanning over two decades, Foronjy’s research has consistently bridged basic science and translational impact, earning him recognition as a critical voice in respiratory toxicology and a trusted authority on the long-term consequences of modern inhalant exposures.
Research Focus
Key Achievements
Top Papers
- 1